I’ve gone here for years now. Highly recommend!
Dr. Michael B. Khoury OD is a male optometrist in Los Angeles, CA with over 25 years of experience. His CareDash rating is 5.0 out of 5 by one patient, and he has one review. Dr. Khoury is affiliated with Michael Khoury OD Inc. in Los Angeles. He received $396 in payments from medical companies between 2014 and 2016, which is more than 56% of Optometrists and more than 56% of providers nationally. Dr. Khoury graduated from Illinois College of Optometry at Chicago in 1993. He is licensed to practice by the state board in California (10204T).
Displaying 1 review
April 13, 2018
Los Angeles, CA
All reviews and ratings are original content posted to CareDash by registered users of the site. Some CareDash reviewers may have received a benefit, like a sweepstakes entry, in exchange for writing a review. Those benefits were not conditioned on the positive or negative content of the review.
Dr. Michael B. Khoury OD graduated from Illinois College of Optometry at Chicago in 1993.
Full Name: Michael B. Khoury
Years of Experience: 25+
License Number: 10204T - Issued by the state board in California
Many providers have received payments from medical companies ranging from small amounts in the form of food at conferences to large payments for consulting or royalties. Some providers have received payments for specific drugs. These payments are not necessarily cause for concern, but we encourage you to speak with your provider if they do raise any questions or issues.
Dr. Khoury received more money than a majority (57%) of optometrists. See the breakdown of payments by category.
Providers receive payments in various different categories, from travel and lodging or food and beverages at conferences to fees for promotional speaking or consulting engagements. Some providers receive payments from royalties or licenses, usually from having helped develop a product or drug.
Providers receive payments from specific medical companies, sometimes for specific drugs. If you have any questions or concerns about the specific company or drug payments your provider has received, we encourage you to speak with your provider directly.